Skip to Main Content

Paper Details

Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial.
Biol Blood Marrow Transplant
40
2015
Author NameAffiliation
Richard T MaziarzKnight Cancer Institute, Center for Hematologic Malignancies, Oregon Health and Science University
Gabrielle MeyersKnight Cancer Institute, Center for Hematologic Malignancies, Oregon Health and Science University
Robert DeansInc.
  • 1 - 3

Datasets

Release 1.2